Author:
Ferment Benoît,Arnulf Bertrand
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference45 articles.
1. SPF, Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018 - Hémopathies malignes : étude à partir des registres des cancers du réseau Francim./import/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-hemopathies-malignes-etude-a-pa (consulté le juin 06, 2021).
2. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group;Palumbo;JCO,2015
3. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study;Kumar;Leukemia,2017
4. A decade of immune-checkpoint inhibitors in cancer therapy;Robert;Nat Commun,2020
5. Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial;Mateos;Lancet Haematol,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献